Study of patients who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just ...

After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

Whether semaglutide (Ozempic, Wegovy) and other GLP-1 drugs as well as new derivatives also reduce stroke risk when used for ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...